Vitamin E does not prevent bone loss and induced anxiety in rats with ligature-induced periodontitis  by Carvalho, Rosimary de Sousa et al.
Vitamin E does not prevent bone loss and induced anxiety in
rats with ligature-induced periodontitis
Rosimary de Sousa Carvalho a,*, Carolina Melo de Souza b,
Julliana Catharina de Souza Neves b, Sergio Arau´jo Holanda-Pinto a,
Lı´via Maria Sales Pinto c, Gerly Anne Castro Brito d, Geanne Matos de Andrade b
aDepartment of Clinical Odontology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Brazil
b Laboratory of Neurosciences and Behavior, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara,
Brazil
cDepartment of Prosthetic Dentistry, Bauru School of Dentistry, University of Sa˜o Paulo, Brazil
dDepartment of Morphology, Faculty of Medicine, Federal University of Ceara, Brazil
a r c h i v e s o f o r a l b i o l o g y 5 8 ( 2 0 1 3 ) 5 0 – 5 8
a r t i c l e i n f o
Article history:







a b s t r a c t
Objective: The purpose of this study was to investigate the effect of vitamin E on alveolar
bone loss (ABL) and anxiety in rats with ligature-induced experimental periodontitis (EP).
Material and methods: Wistar rats were subjected to ligature-induced EP and treated with
vitamin E (500 mg/kg, orally) for 9 days. Then anxiety was tested using the elevated plus-
maze (EPM) test. All of the animals were euthanised by cervical dislocation on day 11. ABL
was analysed morphometrically and histopathologically. Lipid peroxidation quantification,
activity of the enzyme superoxide dismutase and immunohistochemistry to tumour necro-
sis factor-alpha (TNF-a) and inducible isoform of nitric oxide synthases (iNOS) were also
tested.
Results: EP induced a marked inflammatory process and intense ABL. Treatment with
vitamin E decreased inflammatory reaction, prevented malondialdehyde formation and
reduced the immunoreactivity to iNOS, but did not decrease ABL. Vitamin E had an
anxiogenic effect on rats with or without EP.
Conclusions: Vitamin E may have potential to reduce oxidative damage and inflammatory
response in EP but does not prevent ABL. Attention should be given to indiscriminate use of
vitamin E due to the risk of causing anxiety in patients.
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Periodontitis is a ‘‘complex disease’’ and does not have a single
aetiology.1 However, it is commonly described as a chronic
disorder characterised by the breakdown of tooth-supporting
tissues and the impaired host inflammatory immune response
due to an ecological imbalance between the normal microbial
biofilm on teeth and the host tissues.2 Aspects of the* Corresponding author. Tel.: +55 85 3242 32 15; fax: +55 85 3366 83 36
E-mail address: roseperio@yahoo.com.br (R.d.S. Carvalho).
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http://dx.doi.org/10.1016/j.archoralbio.2012.04.020
Open access under the Elsevier OA license. inflammatory and immune processes, both humoral and
cellular, which develop in response to the microbial insult
from dental plaque, could be important in inflammatory
periodontal disease.3 An increased oxidative and nitrosative
stress, which is generally associated with clinical conditions,
such as cardiovascular disease, respiratory infection, diabetes,
metabolic syndrome, and periodontitis, can play a crucial role
in the exacerbation of periodontitis.2,4.
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as a result of both endogenous and exogenous oxidising
agents. Oxidative species, such as superoxide, hydrogen
peroxide, and hydroxyl radicals are common by-products of
normal aerobic metabolism. These ROS are also generated by
the immune system in inflamed or damaged tissues, such as in
periodontitis.5 Although ROS are necessary for defence of the
host, they also expose the host tissue to oxidative damage.
Several studies implicate polymorphonuclear leukocytes
(PMNs) as the primary mediators of a host response against
pathogenic microbes during inflammatory periodontal dis-
eases. Studies demonstrate that PMNs produce a range of
antimicrobial factors, which include ROS, during phagocytosis
of periodontopathic bacteria in inflammatory periodontal
diseases6 that can cause damage to gingival tissue, the
periodontal ligament, and alveolar bone through several
mechanisms.7 These mechanisms include a disruption of
the extracellular matrix,8 induction of lipid peroxidation and
proinflammatory cytokines that cause DNA damage and
oxidation of enzymes, such as antiproteases,9 and increased
apoptosis in the deepest area of the sulcular pocket.10 ROS are
also produced by osteoclasts, which are responsible for bone
destruction, and they may play a role in the remodelling of
alveolar bone in health and disease. Some studies demon-
strated that ROS are capable of degrading alveolar bone
proteoglycans in vitro.8
Vitamin E (alpha-tocopherol), which protects against
lipoperoxidation,11 is the major fat-soluble antioxidant pres-
ent in all cell membranes; it acts as a scavenger of free radicals
and may replace the enzyme glutathione peroxidase in the
decomposition of these radicals.12 It was shown that vitamin E
reduces superoxide production from neutrophils in a concen-
tration-dependent way.13 Other studies described its anti-
inflammatory properties,14,15 whereas a study on the effect of
caloric restriction and a vitamin E-deprived diet on mitochon-
drial structure and features in the liver of rats during ageing
demonstrated that vitamin E-deficient rats appeared older
than their actual ages.16 Vitamin E was then also considered to
be a specific and effective stimulator of the humoral immune
response by stimulating the development and/or proliferation
of antibody-producing cells.17 Several recent studies have
indicated that the total antioxidant capacity of plasma
appears to be compromised in chronic periodontitis,18 and
the intake of micronutrients led to a slight improvement in the
degree of gingival inflammation,19 but the preventive role of
antioxidants still needs further investigation.
There is also evidence that chronic treatment with
antioxidants can benefit cognition in elderly humans and
animals.20 This benefit is most likely due to a reduction in the
oxidative stress that is associated with ageing-related sensi-
tivity to ROS that leads to cell death and cognitive declines.21,22
In addition to its importance for cognition, vitamin E has also
been associated with anxiety. Kolosova et al. showed that
vitamin E increased anxiety in rats 23 and, recently, Hugnes
and Collins noted that vitamin E appears to interfere with the
behaviour of rats, possibly due to the great anxiety that can
accompany its action.24
There has been a tremendous emphasis on the application
of a cost-effective approach to antioxidant therapy within
dental research. The present study aimed to investigate theeffects of vitamin E on the inflammatory response, alveolar
bone loss (ABL) and anxiety, using rats diagnosed with
ligature-induced experimental periodontitis (EP).
2. Materials and methods
2.1. Animals
Male Wistar rats (180–220 g) obtained from the Central Animal
House of the Federal University of Ceara´ were used for the
experiments. The animals were maintained in standard
housing conditions (12-h light/dark cycle at 22  2 8C) with
free access to food (Purina Chow) and water except during the
test period. The experimental protocol for surgical procedures
and animal treatment was approved by the Institutional
Animal Ethics Committee of the Federal University of Ceara´
(protocol no. 052/07).
2.2. Induction of experimental periodontitis (EP)
A sterilised nylon (3-0) thread ligature was placed around the
cervix of the second left upper molar of rats anesthetised with
Xylazine 2% (Kensol1, Ko¨nig, Argentina, 10 mg/kg, IP) and
Ketamine 5% (Vetanarcol1, Ko¨nig, Argentina, 60 mg/kg, IP).
The ligature was knotted on the buccal side of the tooth,
resulting in a subgingival position palatally and in a
supragingival position buccally.25 The upper molar was
chosen because the induced periodontal disease occurs more
rapidly in that location due to the porosity of the spongy bone
in the maxilla, which allows for fast resorption. Additionally,
access is easier for the operator. The contralateral right side
was used as the unligated control. All the animals were
euthanised by cervical dislocation on day 11.
2.3. Drug treatments
Animals were assigned randomly to the following four groups
(18 animals in each experimental group). Group 1: SO (sham-
operated, submitted to the placement and immediate with-
drawal of the nylon ligature around the cervix of second upper
molars and treated with vehicle); Group 2: EP (experimental
periodontitis treated with vehicle); Group 3: SO + Vit E (sham-
operated and treated with vitamin E); and Group 4: EP + Vit E
(EP treated with vitamin E). After the treatment was finished,
the experimental groups were subdivided equally for alveolar
bone resorption, histological, and biochemical (lipid peroxi-
dation and SOD) analysis.
2.4. The plus-maze test
The plus-maze test was performed according to Pellow et al.26
The plus-maze consisted of two open (48 cm  48 cm  12 cm)
and two closed (48 cm  48 cm  12 cm) arms, which were
connected by a central platform (5 cm  5 cm) elevated 50 cm
off of the floor. Rats were placed on the central platform facing
a closed arm. During a 5-min period, the number of entries
made into the open and closed arms, the time spent in each
one and the percentage of time or to the number of entries in
each arm was measured.
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The excised maxillae were fixed in 10% neutral formalin for
24 h. Both maxillary halves were then defleshed and stained
with aqueous methylene blue (1%) to differentiate bone from
teeth. Measurements of bone loss were made along the axis of
each root surfaces of all molar teeth. Three recordings for the
first (three roots) and two recordings for the second and third
molar teeth (two roots each) were made. The total alveolar
bone loss was obtained by taking the sum of the recordings
from the buccal tooth surface and subtracting the values of the
right maxilla (unligated control) from the left one, in
millimetres.25 Morphometric analysis of the alveolar bone
was performed with standardised digital photography (1.5,
SONY-DSC-H5, Japan), and the distance was measured with
the Software Image J1 Toll 1.37 (National Institutes of Health –
NIH, USA).
2.6. Histopathological analysis
The alveolar bone was fixed in 10% neutral buffered
formalin and demineralised in 5% nitric acid. Following
this procedure, these specimens were then dehydrated,
embedded in paraffin, and sectioned along the molars in a
mesio-distal plane for haematoxylin–eosin. Sections of 6 mm
in thickness, corresponding to the area between the first
and second molars where a ligature had been placed, were
evaluated by light microscopy (40). Parameters, such as
inflammatory cell influx, alveolar bone and cementum
integrity were analysed by a histologist in a single-blind
fashion and graded as follows: score 0: absence of or only
discrete cellular infiltration (inflammatory cell infiltration is
sparse and restricted to the marginal gingiva) and preserved
alveolar process and cementum; score 1: moderate cellular
infiltration (inflammatory cellular infiltration present over
the attached gingiva), some but minor alveolar process
resorption, and intact cementum; score 2: accentuated
cellular infiltration (inflammatory cellular infiltration pres-
ent in both gingival and periodontal ligaments), accentuated
degradation of the alveolar process, and partial destruction
of cementum; and score 3: accentuated cellular infiltrate,
complete resorption of the alveolar process, and severe
destruction of cementum.27
2.7. TNF-a and iNOS immunohistochemistry
Thin sections of periodontal tissue (5 mm) were obtained using
a microtome and transferred to a gelatin coated slide. The
tissue section was first deparaffinised and then rehydrated.
The slices were washed with 0.3% Triton X-100 in phosphate
buffer, quenched of endogenous peroxidase (3% hydrogen
peroxide) and incubated with a primary antibody (TNF-a, 1:250
or iNOS, 1:250, Sigma, USA) overnight at 4 8C. After washing
with PBS, the slices were incubated with a secondary antibody
for 1 h. The immunoreactivity to TNF-a was visualised using a
colourimetric-based detection kit following the manufac-
turer’s protocol (Dako LSAB+Kit, peroxidase, AKO, USA), and
the immunoreactivity to iNOS was visualised with an alkaline
phosphatase detection kit (EnVisionTM/AP K1396, Dako
Cytomation kit).2.8. Lipid peroxidation
The levels of thiobarbituric acid reactive substances (TBARS)
in the gingivomucosal tissue were determined as an indicator
of lipid peroxidation as previously described.28 Gingival
tissues were cut into small pieces and then homogenised in
ice-cold phosphate buffer (50 mM pH 7.4) to give a 10%
homogenate. Then, 250 mL of homogenates were transferred
to test tubes and incubated in a water bath at 37 8C for 60 min.
After this period, 400 mL of 35% perchloric acid was added and
centrifuged at 12,000  g for 10 min. To the supernatant
solution, 400 mL of 0.6% thiobarbituric acid solution was
added, and the mixtures were then placed in a water bath
and heated for 30 min at 95–100 8C. After cooling, the
absorbance was measured with a microplate reader at a
wavelength of 532 nm. The standard curve was prepared with
several concentrations of malondialdehyde (MDA) under the
same conditions.
2.9. Superoxide dismutase (SOD) activity
SOD activity was assessed by measuring enzyme capacity for
the photochemical inhibition of nitroblue-tetrazolium
(NBT).29 The reduction of NBT by O2
 was utilised as the
basis of assays for superoxide dismutase, which shows its
presence by inhibiting the reduction of NBT producing
formazan, which is absorbed at 560 nm. Aliquots of tissue
homogenates were centrifuged at 15,000  g for 20 min. In a
dark room, 20 mL of phosphate buffer or supernatants were
added to glass test tubes containing 1 mL of the reaction
mixture (phosphate buffer 50 mM, EDTA 100 nM and L-
methionine 19.5 mM pH 7.8). Then, 150 mL of NBT 750 mM
and 300 mL of riboflavin 10 mM were added. After shaking, the
tubes were exposed to light (20 W) for 15 min. The absorbance
was measured at 560 nm. The results were expressed in
enzyme units, representing the amount of SOD necessary to
inhibit NBT reduction by 50%. The enzymatic activity was
expressed as U/mg of gingival tissue.
2.10. Statistical analysis
All data are presented as the mean  SEM. The results were
analysed using one-way analysis of variance (ANOVA),
followed by Tukey’s Multiple Comparison Test. The Krus-
kal–Wallis and Dunn’s tests were used for histopathological
analysis. A significance level of 0.05 was applied.
3. Results
3.1. Effect of vitamin E treatment in the elevated plus-
maze in rats with EP
The animals with experimental periodontal disease (EP) did
not show anxiolytic behaviour, demonstrated by the lack of a
significant difference between the number of entries and the
permanence time spent in the closed arm compared to the
control. When compared to animals treated with vitamin E, we
observed anxiolytic behaviour in the treated rats. The
permanence time spent in the closed arms was significantly
Table 1 – Effect of vitamin E in the elevated plus-maze in rats with experimental periodontitis (EP).
Groups NEOA NECA PTOA (s) PTCA (s)
SO 4.67  0.50 (35.00) 8.67  0.47 (65.00) 64.00  9.29 (25.93) 182.80  4.81 (74.07)
EP 3.22  0.70 (32.95) 6.56  0.94 (67.05) 37.00  7.70 (15.41) 203.10  12.06 (84.59)
SO + Vit E 2.57  0.72 (21.68) 9.29  1.06 (78.32) 29.86  8.41* (11.36) 232.90  13.38* (88.64)
EP + Vit E 2.50  0.53 (26.32) 7.00  1.28 (73.68) 21.38  4.80* (7.80) 252. 60  8.27* (92.20)
NEOA: number of entries into open arms. NECA: number of entries into closed arms. PTOA: permanence time into open arms. PTCA:
permanence time into closed arms. Vitamin E (500 mg/kg, orally) was administered 1 h before EP induction for 9 days. Values represent
mean  SEM. Parentheses represent the percentage of time or to the number of entries in each arm.
* vs. SO (ANOVA and Tukey test).
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treatment (Table 1).
3.2. Effect of vitamin E treatment on alveolar bone loss in
rats with EP
Rats with EP showed a significant alveolar bone loss compared
to sham-operated (SO = 1.41  0.30 mm; EP = 7.42  1.37 mm;
p < 0.001). It was observed that treatment with vitamin E did
not reverse the alveolar bone loss caused by EP (Fig. 1). These
data are shown in Fig. 2A, which shows the macroscopic
aspects of the sham group (SO) with no resorption of the
alveolar bone when compared to the untreated group (EP),
where severe bone resorption with root exposure is observed
(Fig. 2B). Fig. 2D shows the macroscopic appearance of
periodontium subjected to EP and treated with vitamin E
500 mg/kg, where severe bone loss is observed.
3.3. Effect of vitamin E on inflammatory response induced
by EP in rats
Fig. 3 shows photomicrographs of the periodontium of rats
subjected to EP and treated with vitamin E. The sham-
operated group showed only a little inflammatory cell
infiltrate, and the alveolar process and cementum were
preserved (Fig. 3A; Table 2). The EP group revealed an intenseFig. 1 – Effect of vitamin E treatment on alveolar bone loss
associated with experimental periodontitis (EP) in rats.
Vitamin E (500 mg/kg, orally) was administered 1 h before
ligature placement and once daily for 9 days. Values are
expressed as the mean W SEM, * vs. SO ( p < 0.05, ANOVA
and Tukey’s test).cellular infiltration, resorption of the alveolar process, and
cementum destruction (Fig. 3B; Table 2). Treatment with
vitamin E showed a mild decrease in cellular infiltration that
was not statistically significant (Fig. 3C; Table 2).
3.4. Effect of vitamin E on TBARS concentration in rats
with EP
The lipid peroxidation was evaluated by the formation of
thiobarbituric acid reactive substances (TBARS), represented by
the malondialdehyde (MDA) formation in gingival tissue. Rats
submitted to EP showed a significant increase in lipid
peroxidation compared with the sham-operated group
(SO = 1.97  0.11 mM; EP = 3.13  0.42 mM). Vitamin E treat-
ment significantly reduced the malondialdehyde formation
induced by EP (EP + vitamin E = 1.89  0.35 mM, p < 0.01) (Fig. 4).
3.5. Effect of vitamin E on superoxide dismutase (SOD)
activity in animals with EP
No significant changes in SOD activity were observed in
gingival tissue homogenates of SO, EP and vitamin E only
treated groups. However, SOD activity was found to be
significantly ( p < 0.05) decreased in EP rats treated with
vitamin E (SO = 348.3  55.3 U/mg tissue; EP = 315.9  60.0 U/
mg tissue; vitamin E = 388.1  37.3 U/mg tissue; EP + vitamin
E = 180.8  84.4 U/mg tissue; p < 0.05) (Fig. 5).
3.6. Effect of vitamin E on immunoreactivity for TNF-a
and iNOS
The periodontium of rats diagnosed with EP showed marked
immunoreactivity to both TNF-a and iNOS when compared to
the periodontium of the SO group. Vitamin E 500 mg/kg did not
reduce the TNF-a immunostaining in the periodontium of rats,
but a decrease in iNOS reactivity was apparent (Fig. 6).
4. Discussion
This study used a highly reproducible experimental model of
ligature-induced periodontitis in rats, wherein ligation acts as
a mechanical trauma on the dentogingival area, thereby
reducing tissue integrity and allowing for intense host-plaque
interaction and plaque accumulation, thus increasing the
number of bacteria. These events contribute to changes in the
periodontal tissues similar to those observed in human
periodontitis, including the influx of inflammatory cells and
Fig. 2 – Macroscopic aspects of periodontium of rats with experimental periodontitis disease (EP) that were treated with
vitamin E. (A) Sham-operated (SO) with no resorption of the alveolar bone. (B) EP group, where severe bone resorption with
root exposure is observed. (C) Sham-operated group treated with vitamin E, where no bone resorption is observed. (D)
Periodontium subjected to EP and treated with vitamin E (500 mg/kg, administered orally 1 h before ligature placement and
daily for 9 days), where severe bone loss is observed. Original magnification 1.5T.
Fig. 3 – Effect of vitamin E on the inflammatory response induced by experimental periodontitis (EP) in rats. (A) Sham-
operated showed only mild inflammatory cell infiltrate. The alveolar process and cementum were preserved. (B)
Periodontium of rats subjected to EP and treated with vehicle (oil). There was marked cellular infiltration and resorption of
the alveolar process (only a fragment of the alveolar process is visible, arrow). (C) Periodontium of rat subjected to EP and
treated with vitamin E (500 mg/kg, for 9 days), where the periodontium showed a reduction of cellular infiltration. H&E
staining (400T), scale bar 100 mm. Gingival (g), periodontal ligament (pl), alveolar bone (ab), cementum (c).
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Table 2 – Histopathological analysis of the effect of
vitamin E on the inflammatory response induced by




EP + Vit E (500 mg/kg) 2 (0–3)
Data represent average, minimal and maximal scores as described
in Section 2. SO (sham operated), EP (experimental periodontitis),
and EP + Vit E (vitamin E).
* vs. SO ( p < 0.05, Kruskal–Wallis and Dunn’s test).
Fig. 5 – Effect of vitamin E on superoxide dismutase (SOD)
activity in homogenate of gingival tissue in animals with
EP and treated with vitamin E. Vitamin E was
administered at a dose of 500 mg/kg, orally, 1 h before
induction of EP and daily for 9 days. Enzymatic activity
was expressed as U/mg of tissue. The results are
expressed as the mean W SEM. * vs. SO ( p < 0.01, ANOVA,
Tukey’s test).
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tissues.
We examined the effect of vitamin E (alpha-tocopherol) on
ligature-induced bone loss and inflammatory process because
this substance has antioxidant properties, can strengthen the
immune system, and has anti-inflammatory properties.12,17
Prevention of bone loss has been demonstrated in rats with
experimental periodontitis treated with non-steroidal anti-
inflammatory drugs like cyclooxygenase 2 inhibitors.30 The
results of this study showed that although vitamin E reduces
the inflammatory cell infiltrate, an observation consistent
with previous reports,31 it does not prevent alveolar bone loss.
This differs from the studies of Cohen and Meyer15 that
describe the protective effect of vitamin E supplementation
against bone loss in rats subjected to prolonged stress.
The presence and activation of inflammatory cells in
periodontal exudates may cause the release of various
inflammatory mediators such as cytokines, which might, in
turn, stimulate bone resorption directly by inducing the
proliferation of progenitors of osteoclasts, or indirectly by
stimulating the resorptive activity of mature osteoclasts. In
humans, the activity of iNOS in inflamed gingival tissue has
been shown.32
It was observed that 80% of the recruitment of inflamma-
tory cells and 60% of the bone loss that occurs in periodontitis
can be inhibited by blocking the release of TNF-a and IL-1.Fig. 4 – TBARS concentration in animals with experimental
periodontal (EP) and treated with vitamin E. Vitamin E was
administered at a dose of 500 mg/kg, orally, 1 h before
induction of EP and daily for 9 days. The results are
expressed as the mean W SEM. * vs. SO ( p < 0.01, ANOVA,
Tukey’s test).Other researchers have showed that when TNF-a is inhibited,
there is a significant reduction in bone loss.30,33 In this study,
we observed an increase in TNF-a and iNOS immunoreactivity
in the gingival tissue of rats subjected to EP, and vitamin E
treatment did not reverse the immunoreactivity for TNF-a, but
decreased the immunoreactivity for iNOS. The reduced
expression of iNOS observed in this study is in agreement
with the findings of Yoshida et al.34 and could possibly result
from a direct inhibitory effect of alpha-tocopherol on COX-2
activity. Studies indicate a close relationship between the
production of nitric oxide and periodontal disease, and
changes in the expression of iNOS may have different effects
on periodontal tissues. These effects may be beneficial, such
as antimicrobial activity, or may be harmful, such as cytotoxic
activity, including alveolar bone resorption due to the
stimulating effect of nitric oxide on the activity of osteoclasts.
Studies report an increased activity of iNOS in EP, and its
inhibition may decrease alveolar bone loss.27,35 Interestingly,
Silva et al. demonstrated that iNOS deficiency is associated
with an imbalance in the proinflammatory cytokines (IL-1aˆ
and TNF-a´), bone-resorptive modulators (RANK and RANKL),
and the chemokine MCP-1. Additionally, NO, but not ROS,
controls the progression of bone resorption and may mediate
osteoclast differentiation in a murine experimental model of
apical periodontitis.36
Anxiety is an emotional state emerging under conditions of
indefinite hazards and manifests in the expectation of an
unfavourable course of events, which under natural condi-
tions, helps to adapt to changing environmental conditions.
However, high basal anxiety can become a cause of excessive
stress-reactivity and injuries.23 Previous studies have shown
that the use of vitamin E (alpha-tocopherol) was associated
with anxiogenic behaviour.23,24 In compiling this data, we
observed that vitamin E caused anxiety in animals regardless
of periodontal disease. Not all of the effects of vitamin E are
due to its antioxidant characteristics. Vitamin E, through
Fig. 6 – Photomicrographs of periodontal tissue of rats with EP and treated with vitamin E showing the immunoreactivity to
TNF-a (A–F) and iNOS (G–L). (A, D, G, J) SO: sham-operated rats; (B, E, H, K) rats subjected to EP; (C, F, I, L) rats subjected to EP
and treated with vitamin E (500 mg/kg). (A, B, C, G, H, I) (100T), scale bar = 100 mm; (D, E, F, J, K, L) (400T), bar scale = 50 mm;
pulp (p) gingival (g), periodontal ligament (pl) and dentine (d).
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kinase C, and phosphoinositol-3-kinase, is involved in the
regulation of gene expression.37 A decrease in vitamin E
modifies the expression of various genes in the brain, causing
changes in neuronal plasticity in tocopherol-binding protein
knockout mice. These findings indicate the hazards of
uncontrolled use of little-studied antioxidants because even
vitamin E can cause unexpected negative reactions.
Polymorphonuclear cells (PMNs) have been demonstrated
to produce a range of antimicrobial factors, which include
reactive oxygen species (ROS). While ROS production by PMNsin inflammatory conditions provides a host protective role,
evidence also suggests that ROS production during inflamma-
tory diseases can lead to the destruction of extracellular
matrix components and to connective tissue damage. Reactive
oxygen species have been implicated in the pathogenesis of
several diseases, including periodontal disease.8 It has been
suggested that as a result of stimulation by bacterial antigens,
PMNs produce and release a large quantity of ROS, culminat-
ing in heightened oxidative damage to gingival tissue,
periodontal ligament, and alveolar bone.7 Patients with
periodontitis have a significantly higher level of TBARS than
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of TBARS in gingival tissue is closely associated with
periodontal status and that its measurement can help in
the treatment and monitoring of progression of periodontal
disease. A recent study describing the role of oxidative stress
in alveolar bone loss found that an antioxidant (N-acetylcys-
teine) can inhibit this loss.38 Consistent with an earlier study,
we observed an increase in the TBARS level in rats with EP,39 a
finding that could be effectively suppressed with vitamin E
treatment. SOD catalyses the dismutation of superoxide
radicals to hydrogen peroxide and serves to protect cells
against oxidative stress. SOD accumulation is caused by
augmented ROS via the activation of redox-sensitive trans-
activating factors. In this study, besides the inhibition of lipid
peroxidation, treatment with vitamin E caused a decrease in
SOD activity, which implies a reduced production of ROS and
consequently a reduced oxidative stress to periodontal
tissues.
In conclusion, our results suggest that vitamin E could
improve the inflammatory process in the rat model of ligature-
induced experimental periodontitis. However, vitamin E
showed no protection against alveolar bone loss associated
with experimental periodontitis and, moreover, demonstrated
an anxiogenic effect. Thus, the possibility of using this
compound as adjunct therapy deserves further investigation.
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